Silgan Holdings (SLGN) CEO granted 105,000 performance-based RSUs in Form 4

Rhea-AI Filing Summary

Silgan Holdings Inc.'s President and CEO Adam J. Greenlee reported an equity award tied to prior performance. He acquired 105,000 shares of Common Stock at a price of $0.0000 per share through a grant, reflecting the earning of a performance-based award originally granted on March 1, 2025 under the company’s stock incentive plan. The filing notes that 2025 performance criteria were met after finalizing audited 2025 financial statements, so these restricted stock units are no longer subject to cancellation and will vest in equal parts on March 1, 2026, March 1, 2027, and March 1, 2028, settling into Common Stock on a 1-for-1 basis. Following this acquisition, Greenlee directly holds 433,164 shares in total, including 316,793 restricted stock units that are not yet vested.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Greenlee Adam J

(Last) (First) (Middle)

C/O SILGAN HOLDINGS INC.

601 MERRITT 7, FLOOR 1

(Street)

NORWALK CT 06851

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SILGAN HOLDINGS INC [ SLGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A		105,000	A	(1)	433,164(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On March 1, 2025, the reporting person was granted a performance award of 105,000 restricted stock units under the Silgan Holdings Inc. Second Amended and Restated 2004 Stock Incentive Plan, subject to the satisfaction of certain performance criteria for the Issuer's 2025 fiscal year. The performance criteria for the Issuer's 2025 fiscal year was determined to have been met upon the finalization of the Issuer's audited financial statements for 2025. Accordingly, these restricted stock units are no longer subject to cancellation. These restricted stock units vest ratably beginning on March 1, 2026 and on each March 1 thereafter through March 1, 2028 and will be settled in shares of Common Stock on a 1-for-1 basis.

2. This amount includes 316,793 restricted stock units that are not yet vested that have been granted under equity compensation plans of Silgan Holdings Inc. Upon vesting, these restricted stock units will be settled in shares of Common Stock on a 1-for-1 basis.

Remarks:

	/s/ Adam J. Greenlee	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Silgan Holdings (SLGN) report for Adam J. Greenlee?

Silgan Holdings reported that President and CEO Adam J. Greenlee acquired 105,000 shares of Common Stock via a performance-based equity grant at $0.0000 per share. This reflects restricted stock units earned after the company’s 2025 performance criteria were determined to be met.

How were Adam J. Greenlee’s 105,000 Silgan (SLGN) shares earned?

The 105,000 shares stem from a performance award of restricted stock units granted on March 1, 2025. These units became earned once Silgan’s 2025 fiscal year performance criteria were confirmed as met after finalizing the company’s audited 2025 financial statements.

What is the vesting schedule for Adam J. Greenlee’s new Silgan (SLGN) equity award?

The 105,000 restricted stock units will vest ratably on March 1, 2026, March 1, 2027, and March 1, 2028. Upon each vesting date, the units will be settled in Silgan Common Stock on a 1-for-1 basis, increasing his deliverable share holdings over time.

How many Silgan (SLGN) shares does Adam J. Greenlee own after this Form 4 transaction?

After the reported transaction, Adam J. Greenlee directly holds 433,164 shares of Silgan Common Stock. This amount includes 316,793 restricted stock units that are not yet vested, which will convert into shares on a 1-for-1 basis as they vest under existing equity compensation plans.

Was cash paid for Adam J. Greenlee’s latest Silgan (SLGN) share acquisition?

No cash was paid for these shares; the transaction lists a price of $0.0000 per share. The shares result from a performance-based restricted stock unit grant, which became earned after Silgan’s 2025 performance targets were determined to have been satisfied according to the plan’s criteria.

What equity plans govern Adam J. Greenlee’s Silgan (SLGN) restricted stock units?

The 105,000 performance-based restricted stock units were granted under the Silgan Holdings Inc. Second Amended and Restated 2004 Stock Incentive Plan. An additional 316,793 unvested restricted stock units were granted under Silgan’s equity compensation plans and will settle in Common Stock on a 1-for-1 basis upon vesting.